Related Experiment Video
Updated: Jun 7, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.7K
Coronavirus Disease-2019 in the Immunocompromised Host
Christopher D Bertini1, Fareed Khawaja2, Ajay Sheshadri3
1Department of Internal Medicine, UTHealth Houston McGovern Medical School, 6431 Fannin, MSB 1.150, Houston, TX 77030, USA.
Rheumatic Diseases Clinics of North America
|November 16, 2024
Summary
Immunocompromised patients face severe outcomes from COVID-19, including higher mortality. Current treatments and vaccines show variable effectiveness, highlighting the need for specific strategies for this vulnerable population.
Area of Science:
- Immunology
- Infectious Diseases
- Public Health
Background:
- Immunocompromised individuals, including those with cancer, organ transplants, and autoimmune diseases, are at high risk for severe COVID-19.
- These patients experience disproportionately higher rates of severe illness, hospitalization, and death from coronavirus disease-2019 (COVID-19).
Purpose of the Study:
- To review the specific impact of COVID-19 on immunocompromised patient populations.
- To identify knowledge gaps and areas requiring further research regarding COVID-19 in immunocompromised individuals.
Main Methods:
- Literature review focusing on clinical outcomes and treatment efficacy in immunocompromised patients with COVID-19.
- Analysis of current data on vaccines, monoclonal antibodies, and convalescent plasma in this population.
Main Results:
- Immunocompromised patients exhibit significantly worse COVID-19 outcomes compared to immunocompetent individuals.
- Existing interventions like vaccines and antibody therapies demonstrate inconsistent efficacy in this group.
Conclusions:
- There is a critical need for tailored treatment and prevention strategies for immunocompromised patients battling COVID-19.
- Further research is essential to address the unique challenges and improve outcomes for this vulnerable population.
More Related Videos
Related Concept Videos
01:25Immunodeficiency Diseases
909
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
909
01:26Factors Affecting the Risk of Infection
11.4K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.4K
01:29Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
01:25Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
01:30Pneumonia I: Introduction
211
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
211
01:20COPD: Pathogenesis and Clinical Features
235
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
235